However, we found a significantly lower proportion of CD4+CD25+ as well as CD25+FOXP3+ cells in the BM in comparison with the peripheral blood in both OA and RA patient groups (Figure 2c,d). The gene discussed is FOXP3; the disease is rheumatoid arthritis.